顔用注射剤の世界市場 - 市場規模、シェア、成長分析：タイプ別（ボツリヌス毒素、コラーゲン）、用途別（しわ改善、フェイスリフト）、エンドユーザー別（病院、外来手術センター） - 業界予測（2023年～2030年）

顔用注射剤の市場規模は2021年に161億米ドル、2022年に175億6,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に9.1%のCAGRで拡大し、2030年には344億9,000万米ドルに拡大すると予測されています。

世界の顔用注入剤市場は、若々しい外見への願望の高まりや美容治療に対する意識の高まりなどの要因によって、大きな成長を遂げています。皮膚充填剤やボツリヌス毒素を含む顔用注射剤は、しわの減少、唇の増大、顔の輪郭形成に広く使用されています。この市場は、技術の進歩、可処分所得の増加、美意識の拡大によって活性化されています。低侵襲手術に対する需要の高まりと高齢化人口の増加が、今後数年間の市場成長をさらに促進すると予想されます。

予測期間中、環境汚染物質や多様なライフスタイルの選択が皮膚の健康に及ぼす有害な影響により、顔用注射剤の需要が増加すると予想されます。これらの注入剤は、コラーゲン繊維、ヒアルロン酸フィラー、合成フィラーで構成されています。

しかし、厳しい規制、製品の使用制限、発疹や発赤などの皮膚問題の発生が市場の拡大を妨げています。これらの障害は、特に美容用途において市場の成長を阻害しています。

市場の顕著な動向は、男性の間で顔用注射剤の採用が拡大していることです。予測期間中、ボツリヌス毒素や皮膚充填剤を含む様々な充填剤を男性がますます受け入れるようになると予想されます。例えば、若い男性は老化に対抗する手段として組織充填剤を選択しています。このように男性の間で顔用注射剤が受け入れられつつあることが、使用量の増加に寄与していると思われます。

当レポートは、世界の顔用注射剤市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場分析

市場規模

• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題

主要な市場の洞察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 動向分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品分析
• マクロ経済指標
• トップ投資分析
• 主な成功要因
• 競合の程度

市場力学と展望

• 市場力学
• 促進要因
• 機会
• 抑制要因
• 課題
• 規制状況
• ポーター分析

世界の顔用注射剤市場、タイプ別

• 市場概要
• ボツリヌス毒素
• コラーゲン
• ヒアルロン酸
• カルシウム水酸アパタイト
• ポリ乳酸
• ポリメチルメタクリレートマイクロスフェア（PMMA）
• 脂肪注入
• その他

世界の顔用注射剤市場、用途別

• 市場概要
• しわ改善
• フェイスリフト
• ニキビ跡治療
• 口唇拡大術
• 脂肪萎縮症の治療
• その他

世界の顔用注射剤市場、エンドユーザー別

• 市場概要
• 病院
• 外来手術センター
• 皮膚科
• 美容クリニック
• その他

世界の顔用注射剤市場、地域別

• 市場概要
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

競合情勢

• 主要企業プロファイル
  • Allergan
  • Galderma S.A.
  • Merz Pharma
  • Sanofi S.A.
  • Sinclair Pharma
  • Suneva Medical
  • Teoxane Laboratories
  • Anika Therapeutics
  • Anteis S.A.
  • BioPolymer GmbH &Co. KG
  • Cynosure, Inc.
  • Ipsen Group
  • Medytox, Inc.
  • Polymekon s.r.o.
  • Prollenium Medical Technologies Inc.
  • Q-Med AB
  • Revance Therapeutics, Inc.
  • SciVision Biotech Inc.
  • Syneron Medical Ltd.
  • VisionMed Inc

Facial Injectables Market size was valued at USD 16.1 billion in 2021 and is poised to grow from USD 17.56 billion in 2022 to USD 34.49 billion by 2030, growing at a CAGR of 9.1% in the forecast period (2023-2030).

The global facial injectables market is experiencing significant growth, driven by factors such as the increasing desire for youthful appearance and rising awareness of aesthetic treatments. Facial injectables, including dermal fillers and botulinum toxin, are widely used for wrinkle reduction, lip augmentation, and facial contouring. The market is fueled by advancements in technology, growing disposable income, and expanding aesthetic consciousness. Rising demand for minimally invasive procedures and the growing aging population are expected to further drive the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Facial Injectables and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The global facial injectables market is segmented based on type, application, end-user, and region. Based on type, the facial injectables market is segmented as botulinum toxin, collagen, hyaluronic acid, calcium hydroxyl apatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, others. Based on application, the facial injectables market is segmented as wrinkle reduction, facelift, acne scar therapy, lip augmentation, lipoatrophy treatment, others. Based on end-users, the market is segmented as hospitals and ambulatory surgery centers, dermatology and cosmetic clinics, and others. Based on region, the facial injectables market segmentation spans North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

During the projected period, the demand for facial injectables is expected to increase due to the detrimental effects of environmental pollutants and diverse lifestyle choices on skin health. These injectables consist of collagen fibers, hyaluronic acid fillers, and synthetic fillers..

Restrain

However, the expansion of the market is hindered by stringent regulations, limitations on product usage, and the occurrence of skin issues such as rashes and redness. These obstacles impede the market's growth, particularly in terms of aesthetic applications

Trend

A notable trend in the market is the growing adoption of facial injectables among men. Over the forecast period, it is expected that men will increasingly embrace various fillers, including botulinum toxin and dermal fillers. For example, younger men are choosing tissue fillers as a means to combat aging. This increasing acceptance of facial injectables among the male population is likely to contribute to their higher usage.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Facial Injectables Market by Type
  • Market Overview
  • Botulinum Toxin
  • Collagen
  • Hyaluronic Acid
  • Calcium Hydroxyl Apatite
  • Polylactic Acid
  • Polymethyl-Methacrylate Microspheres (PMMA)
  • Fat Injection
  • Others
• Global Facial Injectables Market by Application
  • Market Overview
  • Wrinkle Reduction
  • Facelift
  • Acne Scar Therapy
  • Lip Augmentation
  • Lipoatrophy Treatment
  • Others
• Global Facial Injectables Market by End-User
  • Market Overview
  • Hospitals
  • Ambulatory Surgery Centers
  • Dermatology
  • Cosmetic Clinics
  • Others
• Global Facial Injectables Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Allergan
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Galderma S.A.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merz Pharma
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi S.A.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sinclair Pharma
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Suneva Medical
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teoxane Laboratories
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Anika Therapeutics
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Anteis S.A.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • BioPolymer GmbH & Co. KG
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cynosure, Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ipsen Group
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medytox, Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Polymekon s.r.o.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Prollenium Medical Technologies Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Q-Med AB
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Revance Therapeutics, Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • SciVision Biotech Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Syneron Medical Ltd.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • VisionMed Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments